David Messenheimer

David Messenheimer is a Research Scientist IV at the University of Washington, specializing in translational immunology. He has a strong focus on developing combination immunotherapy strategies, particularly involving cancer vaccines. His research interests include understanding tumor immunity and the application of proteogenomics to identify novel cancer antigens.

Education and Experience

• Education: Messenheimer completed his studies at Oregon Health and Science University, where he developed a solid foundation in immunology.
• Professional Background: He is recognized for his collaborative approach in building research teams and has contributed significantly to the field through various presentations and publications. His work often involves invited talks at prestigious conferences, showcasing advancements in immunotherapy and cancer treatment strategies.123

Contributions to Immunology

Messenheimer has been actively involved in:

• Presenting at international conferences such as the European Society for Medical Oncology (ESMO) and the National Cancer Institute (NCI).
• Researching the efficacy of cancer vaccines and their role in combination therapies, aiming to improve patient outcomes in oncology.12

His LinkedIn profile indicates that he is inquisitive and dedicated to advancing the field of immunology through innovative research practices.2